Last 1.91 INR
Change Today 0.00 / 0.00%
Volume 0.0
As of 6:00 AM 09/29/14 All times are local (Market data is delayed by at least 15 minutes).

kdl biotech ltd (KOPD) Snapshot

Open
1.91
Previous Close
1.91
Day High
1.91
Day Low
1.91
52 Week High
06/13/14 - 4.00
52 Week Low
11/12/13 - 1.61
Market Cap
45.9M
Average Volume 10 Days
4.2
EPS TTM
-6.74
Shares Outstanding
24.0M
EX-Date
09/25/06
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KDL BIOTECH LTD (KOPD)

Related News

No related news articles were found.

kdl biotech ltd (KOPD) Related Businessweek News

No Related Businessweek News Found

kdl biotech ltd (KOPD) Details

KDL Biotech Limited engages in the manufacture and sale of pharmaceutical products primarily in India. The company is based in Khopoli, India.

kdl biotech ltd (KOPD) Top Compensated Officers

Director of Technical and Executive Director
Total Annual Compensation: 2.1M
Compensation as of Fiscal Year 2012.

kdl biotech ltd (KOPD) Key Developments

KDL Biotech Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2013

KDL Biotech Limited announced audited standalone earnings results for the fourth quarter and full year ended March 31, 2013. For the quarter, the company reported net sales of INR 16.123 million against INR 27.51 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 19.99 million against INR 35.508 million a year ago. Loss from ordinary activities before tax was INR 36.06 million against INR 50.93 million a year ago. Net loss was INR 36.06 million against INR 50.93 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 1.50 against INR 2.12 a year ago. For the year, the company reported net sales of INR 62.42 million against INR 85.02 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 97.06 million against INR 111.99 million a year ago. Loss from ordinary activities before tax was INR 162.08 million against INR 172.12 million a year ago. Net loss was INR 162.08 million against INR 172.12 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 6.74 against INR 7.16 a year ago.

KDL Biotech Limited to Report Q4, 2013 Results on May 29, 2013

KDL Biotech Limited announced that they will report Q4, 2013 results on May 29, 2013

KDL Biotech Limited, Board Meeting, May 29, 2013

KDL Biotech Limited, Board Meeting, May 29, 2013. Agenda: To consider and approve the audited financial results of the Company for the quarter and year ended March 31, 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KOPD:IN 1.91 INR 0.00

KOPD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KOPD.
View Industry Companies
 

Industry Analysis

KOPD

Industry Average

Valuation KOPD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KDL BIOTECH LTD, please visit www.kdlbiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.